Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.3.1.900
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Income Statement [Abstract]    
Research and development expense $ 81,588 $ 156,762
General and administrative expense 5,334,564 $ 4,708,163
Impairment charges 1,387,100
Loss from operations (6,803,252) $ (4,864,925)
Interest expense, net (151,976) (314,316)
Net loss $ (6,955,228) $ (5,179,241)
Net loss per share, basic and diluted $ (0.11) $ (0.13)
Weighted average number of common shares outstanding, basic and diluted 62,707,874 41,079,452